Covered entities often use contract pharmacies to reach patients outside their own locations. The covered entity buys drugs at a discounted 340B price, and the contract pharmacy gives these drugs to eligible patients. This setup makes it easier for patients to get medicines, especially in rural or underserved areas.
There are rules set by the Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs (OPA) that must be followed. Covered entities have to make written contracts with contract pharmacies that list all pharmacy locations involved. Both parties must sign this contract before they register the pharmacy in the 340B Office of Pharmacy Affairs Information System (OPAIS), which is the database where all contract pharmacies are tracked.
Written Agreements
The contract between the covered entity and the pharmacy must clearly list every pharmacy location that will give out 340B drugs. It should explain each party’s duties, rules for following regulations, what reports are needed, and how to handle problems if rules are broken. The contract must be signed before the pharmacy is registered in OPAIS.
Registration and Timely Updates
Contract pharmacies need to register in the 340B OPAIS during open registration periods. These happen every quarter: January 1-15, April 1-15, July 1-15, and October 1-15. The covered entity’s Authorizing Official (AO) and Primary Contact (PC) handle registration. If registration is not approved within 15 days, it will be canceled until the next window. Any changes like new owners, location moves, or DEA number updates must be immediately reported to OPAIS to stay compliant.
Medicaid Carve-Out Compliance
Duplicate discounts happen when 340B drugs are discounted twice, which is not allowed. Contract pharmacies cannot give 340B drugs to Medicaid fee-for-service patients unless there is an agreement with the state Medicaid office to stop double discounts. This agreement must be reported to HRSA. If no agreement exists, Medicaid patients must be excluded from 340B drug dispensing at contract pharmacies.
Oversight and Audits
Covered entities are responsible for making sure their contract pharmacies follow the 340B rules. They must have independent audits every year to check contracts, drug dispensing records, policies, and risk controls. Audits make sure only eligible patients get 340B drugs and there is no illegal resale or diversion. If any problems are found, they must be reported to HRSA right away with plans to fix them.
Record Keeping and Reporting
Both the covered entities and contract pharmacies must keep records that can be checked about drug buying, dispensing, and finances. Contract pharmacies must give detailed reports every quarter on the drugs given and money involved to the covered entities. Good record keeping helps with audits and staying following rules.
Technical Assistance for Ownership Changes
If a contract pharmacy changes owners or joins a new chain, covered entities should help make the change smooth. The 340B Prime Vendor Program (PVP), run by Apexus, can give guidance on how to register and handle technical steps to avoid interruptions or breaking the rules. Not acting quickly during ownership changes can cause registrations to become invalid and stop access to 340B prices.
HRSA carries out about 200 audits every year to make sure covered entities follow 340B program rules. These audits check if the entities have written contracts for contract pharmacies, keep registrations updated, do regular audits, and follow rules to prevent diversion and duplication.
If the rules are not followed, there can be penalties like fines, loss of 340B eligibility, or needing to pay back discounts that were not allowed. That’s why covered entities, including medical practice administrators and owners, must have strong systems to stay compliant.
Since 2012, HRSA audits have become stricter. Covered entities must show yearly proof that they follow program rules and are ready to report any violations. Being open and keeping complete documents help lower audit risks and keep the program running well.
Managing many contract pharmacy relationships can be hard, especially for larger covered entities with pharmacies across many places. Artificial intelligence (AI) and automation can help make the work easier and keep the program rules on track.
AI-Powered Data Integration and Verification
AI tools can combine different pharmacy data like dispensing records, registration info, and Medicaid billing into one system. They can find problems like drug diversion or wrong Medicaid claims before they cause issues.
Automated Contract Monitoring
AI systems designed with 340B rules can check contracts automatically to make sure they meet HRSA guidelines. They can send alerts to staff when contracts need to be renewed, changed, or registered on time.
Real-Time Reporting
Automation can create reports on drug dispensing, finances, and audit documents right away. This cuts down on mistakes and speeds up required reports to covered entities and regulators each quarter.
Compliance Risk Scoring
By studying past audit data and pharmacy patterns, AI can give risk scores to contract pharmacies. Those with higher risk get more checks, so resources are used well and compliance stays strong.
Workflow Optimization for Registration and Updates
AI systems can help with registrations during open windows by guiding through the steps needed in OPAIS. Automated reminders for DEA numbers, addresses, and owners help avoid errors or missed registrations.
Integration with Electronic Health Records (EHR)
Contract pharmacy processes can connect with EHR systems at covered entities to make sure only eligible patients—those with a real relationship with the covered entity—get 340B drugs at contract pharmacies. This helps follow patient eligibility rules strictly.
Establish Clear Contracts: Use written agreements that list all clinics and pharmacies and state compliance needs. Review and update contracts often.
Maintain Accurate OPAIS Registrations: Use checklists and calendars that match registration windows. Assign specific people as Authorizing Official and Primary Contact to avoid missing deadlines.
Enforce Medicaid Carve-Out Policies: Work with state Medicaid offices to set up agreements if Medicaid patients are included. If not, make sure Medicaid patients are excluded from 340B drugs and keep written policies.
Invest in Annual Independent Audits: Plan and budget for outside audits to find and fix compliance gaps. Use audit results to get better and avoid HRSA penalties.
Adopt AI and Automation Tools: Think about using AI software for contract checking, report making, registration tracking, and risk scoring. This lowers manual work and improves accuracy.
Train Staff on Compliance Rules: Make sure administrative and pharmacy workers know 340B rules, especially about patient eligibility, contracts, and reports.
Coordinate with 340B Prime Vendor Program: Stay in touch with Apexus for help with technical questions, legal updates, training, and pharmacy changes.
By using these best practices, medical managers and pharmacy staff can keep steady access to discounted drugs through contract pharmacies. This helps patients get the medicines they need and supports covered entities in using federal resources well. It also lowers risks in pharmacy operations and keeps eligibility for the program.
Using technology like AI combined with following rules makes operations run smoother and cuts down chances of penalties or audit problems. In a changing regulatory setting for the 340B program, these tools and steps are important.
The 340B Drug Pricing Program is an important way for healthcare providers to give medicines at lower prices. For medical practices in the United States, strong contract pharmacy management with good oversight, compliance checks, and technology is necessary to make the program work well and follow the rules.
The 340B Drug Pricing Program allows eligible covered entities to purchase outpatient drugs at discounted prices to extend federal resources, enabling them to reach more patients and provide comprehensive services.
A contract pharmacy arrangement allows covered entities to dispense 340B drugs through external pharmacies. To be compliant, these arrangements must meet the requirements outlined by the HRSA.
The written contract must specify all pharmacy locations involved in the arrangement and must be finalized and signed before registration with the Office of Pharmacy Affairs (OPA).
Contract pharmacies must register with the OPA before dispensing 340B drugs. Both the covered entity and the pharmacy must sign the Contract Pharmacy Registration Form to be recognized.
If a contract pharmacy changes ownership, the covered entity must submit a new registration with the OPA and terminate the old registration to continue the arrangement legally.
Contract pharmacies may not dispense 340B drugs to Medicaid patients unless an arrangement is established to prevent duplicate discounts, which must be reported to the OPA.
Covered entities must perform vigilant oversight of their contract pharmacies, ensuring compliance with 340B requirements and conducting independent audits at least annually.
HRSA audits check for written agreements, timely registration of contract pharmacies, oversight evidence, written policies on compliance, and evidence of actual pharmacy utilization.
Non-compliance can lead to financial penalties, loss of eligibility for the program, and potential audits that could uncover irregularities in the distribution of 340B drugs.
Covered entities can seek assistance from ApexusAnswers, a service of the 340B contracted Prime Vendor Program, via their website or by contacting them through phone or email.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
